Ads
related to: focal prostate ablation success rate by dr john sirak
Search results
Results from the WOW.Com Content Network
Irreversible electroporation (IRE) is an emerging focal therapy for prostate cancer, particularly suitable for small tumors confined to the prostate. Unlike traditional treatments such as radical prostatectomy or radiation therapy, which may lead to side effects like urinary incontinence and erectile dysfunction, IRE aims to minimize such risks ...
Transurethral needle ablation can be used to treat benign prostatic hyperplasia (BPH). [ 4 ] Some clinical studies have reported that TUNA is safe and effective, improving the urine flow with minimal side effects when compared with other procedures, such as transurethral resection of the prostate (TURP) and open prostatectomy .
Studies on localized prostate cancer showed that, after treatment, progression-free survival rates were high for low- and intermediate- risk patients with recurrent prostate cancer. [2] The InsighTec ExAblate 2000 was the first MRgFUS system to obtain FDA market approval, [3] US patent 5,247,935.
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones , such as testosterone , to grow.
Prostate laser surgery is used to relieve moderate to severe urinary symptoms caused by prostate enlargement. The surgeon inserts a scope through the penis tip into the urethra. A laser passed through the scope delivers energy to shrink or remove excess tissue that is preventing urine flow. [7] Different types of prostate laser surgery include:
Pulsed field ablation (PFA) is a non-thermal (not using extreme heat or cold) method of biological ablation (removal of structure or functionality) utilizing high-amplitude pulsed (microsecond duration) electric fields to create irreversible electroporation in tissues. [1] [2] It is used most widely to treat tumors or cardiac arrhythmias. [3]
Using real-world data, researchers found that 81.6% of patients were free from AFib one year after RF-based ablation - a higher percentage than attained in clinical trials.
At the same time, physicians, including Dr. Ablin and Dr. Gage, started utilizing cryoablation for the treatment of prostate and bone cancer. [18] [19] Dr. Paul J. Wang MD and Dr. Peter L. Friedman MD, PhD invented cryoablation for the heart and cardiac arrhythmia in 1988. Their patents were for the cryoablation catheter and cryogenic mapping ...
Ads
related to: focal prostate ablation success rate by dr john sirak